Burden of Clostridium (Clostridioides) difficile Infection among Patients in Western Asia: A Systematic Review and Meta-Analysis

Background: Clostridium difficile is the most common causes of hospital-acquired diarrhea affecting particularly hospitalized patients globally. This organism has re-emerged in recent years with significant morbidity and mortality. The present study aimed to estimate the burden of C. difficile infection (CDI) and to acquire information on the overall rates of community- and hospital-acquired CDI in western Asia. Methods: A systematic literature search was performed to identify articles published from the eight Persian Gulf countries in western Asia including Iran, Iraq, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates in the electronic databases within Jan of 2000 to Dec of 2017. Then, 20 publications which met our inclusion criteria were selected for data extraction and analysis by Comprehensive Meta-Analysis Software. Results: Twenty studies reported the prevalence of toxigenic strains of C. difficile among patients from Persian Gulf countries, of these the pooled prevalence of CDI was 9% (95% CI: 6.5%–12.5%). Totally, 8 studies showed the prevalence of hospital-acquired CDI, from those studies the prevalence of CDI was estimated 8.4% (95% CI: 4.9%–14.1%). Moreover, 7 studies reported the prevalence of community-acquired CDI, from those studies the prevalence of CDI was estimated 1.8% (95% CI: 1.2%–2.9%). Conclusion: The prevalence of CDI in western Asia is lower than southern and eastern region. Moreover, the lower prevalence of community-acquired CDI compared to hospital-acquired CDI, indicate that the source of infection in western Asia is more likely in the hospitals.

[1]  I. Nikokar,et al.  A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran. , 2018, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[2]  H. Goudarzi,et al.  Clostridium difficile infection in hospitalized patients with 1 antibiotic-associated diarrhea : A systematic review and meta-2 analysis , 2018 .

[3]  Soon Sung Kwon,et al.  Clinical and molecular characteristics of community-acquired Clostridium difficile infections in comparison with those of hospital-acquired C. difficile. , 2017, Anaerobe.

[4]  M. Zali,et al.  Molecular typing of Clostridium difficile isolates cultured from patient stool samples and gastroenterological medical devices in a single Iranian hospital. , 2017, Anaerobe.

[5]  N. Nakhaee,et al.  Frequency of antibiotic associated diarrhea caused by Clostridium difficile among hospitalized patients in intensive care unit, Kerman, Iran , 2017, Gastroenterology and hepatology from bed to bench.

[6]  A. Senok,et al.  Detection of Clostridium difficile antigen and toxin in stool specimens: Comparison of the C. difficile quik chek complete enzyme immunoassay and GeneXpert C. difficile polymerase chain reaction assay , 2017, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[7]  N. Amirmozafari,et al.  Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis , 2017, Journal of chemotherapy.

[8]  S. Hutfless,et al.  The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact , 2017, PloS one.

[9]  W. Ba-Thein,et al.  Clostridium difficile-associated clinical burden from lack of diagnostic testing in a Chinese tertiary hospital. , 2016, The Journal of hospital infection.

[10]  L. Cui,et al.  The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis , 2016, Scientific Reports.

[11]  V. Rotimi,et al.  Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait , 2016, PloS one.

[12]  C. Suetens,et al.  Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  M. Albert,et al.  Evaluation of the xTAG Gastrointestinal Pathogen Panel Assay for the Detection of Enteric Pathogens in Kuwait , 2016, Medical Principles and Practice.

[14]  P. Ascenzi,et al.  Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects , 2016, Toxins.

[15]  S. Razavi,et al.  Antimicrobial resistance pattern and genetic correlation in Enterococcus faecium isolated from healthy volunteers. , 2016, Microbial pathogenesis.

[16]  H. Ashwin,et al.  Standardised surveillance of Clostridium difficile infection in European acute care hospitals : a pilot study , 2016 .

[17]  M. Barati,et al.  Hospital acquired diarrhea in a burn center of Tehran , 2015, Iranian journal of microbiology.

[18]  Meenakshi Singh,et al.  Prevalence and molecular types of Clostridium difficile isolates from faecal specimens of patients in a tertiary care centre. , 2015, Journal of medical microbiology.

[19]  V. Rotimi,et al.  A prospective study of community-associated Clostridium difficile infection in Kuwait: Epidemiology and ribotypes. , 2015, Anaerobe.

[20]  A. Balouchi,et al.  Knowledge, Attitude and Practice of Nurses about Standard Precautions for Hospital-Acquired Infection in Teaching Hospitals Affiliated to Zabol University of Medical Sciences (2014) , 2015, Global journal of health science.

[21]  Bin Liu,et al.  A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity , 2015, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[22]  J. Stausberg Epidemiology of clostridium difficile infection. , 2015, Deutsches Arzteblatt international.

[23]  D. Leffler,et al.  Clostridium difficile infection. , 2015, The New England journal of medicine.

[24]  K. Garey,et al.  Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples , 2015, Annals of laboratory medicine.

[25]  M. Mulvey,et al.  Emergence of an Outbreak-Associated Clostridium difficile Variant with Increased Virulence , 2015, Journal of Clinical Microbiology.

[26]  C. Surawicz Clostridium Difficile Infection: Risk Factors, Diagnosis and Management , 2015, Current Treatment Options in Gastroenterology.

[27]  V. Rotimi,et al.  Comparative performance of the GeneXpert C. difficile PCR assay and C. diff Quik Chek Complete kit assay for detection of Clostridium difficile antigen and toxins in symptomatic community-onset infections. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[28]  S. Dancer,et al.  Controlling Hospital-Acquired Infection: Focus on the Role of the Environment and New Technologies for Decontamination , 2014, Clinical Microbiology Reviews.

[29]  D. Perlin,et al.  Clostridium difficile infection in Brazil: a neglected problem? , 2014, American journal of infection control.

[30]  W. Hamdi,et al.  Polymerase chain reaction ribotyping of Clostridium difficileisolates in Qatar: a hospital-based study , 2014, BMC Infectious Diseases.

[31]  A. Alborzi,et al.  Prevalence and risk factors of Clostridium difficile - associated diarrhea in Iranian hospitalized patients , 2013 .

[32]  H. Goudarzi,et al.  Antimicrobial Susceptibility of Clostridium Difficile Clinical Isolates in Iran , 2013, Iranian Red Crescent medical journal.

[33]  M. Zali,et al.  The Frequency of Toxigenic Strains of Clostridium difficile in Hospitalized Patients with Diarrhea in Tehran/Iran by PCR Method, 2010 , 2013 .

[34]  F. Al-Eidan PROTON PUMP INHIBITORS AND THE INCREASED RISK OF CLOSTRIDIUM DIFFICILE INFECTIONS: A CASE-CONTROL STUDY , 2013 .

[35]  F. Khan,et al.  Epidemiological features of Clostridium difficile infection among inpatients at Hamad General Hospital in the state of Qatar, 2006-2009. , 2012, Travel medicine and infectious disease.

[36]  A. Revelas Healthcare – associated infections: A public health problem , 2012, Nigerian medical journal : journal of the Nigeria Medical Association.

[37]  Mohammad Mahdi Jalali,et al.  Clostridium difficile infection in an Iranian hospital , 2012, BMC Research Notes.

[38]  M. Zali,et al.  Frequency of Clostridium difficile among patients with gastrointestinal complaints , 2011, Gastroenterology and hepatology from bed to bench.

[39]  E. Kuijper,et al.  Clostridium difficile infection in Europe: a hospital-based survey , 2011, The Lancet.

[40]  V. Rotimi,et al.  Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period. , 2010, Anaerobe.

[41]  J. Al-Tawfiq,et al.  Clostridium difficile-associated disease among patients in Dhahran, Saudi Arabia. , 2010, Travel medicine and infectious disease.

[42]  M. Salari,et al.  The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers. , 2010, Acta medica Iranica.

[43]  S. Alrifai,et al.  Prevalence and etiology of nosocomial diarrhoea in children < 5 years in Tikrit teaching hospital. , 2009, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[44]  K. Al-Ali,et al.  Infectious Nosocomial Diarrhea in the Surgical Wards: Role of Parasites and Microbes Imply Stool Analysis , 2009 .

[45]  G E Bignardi,et al.  Risk factors for Clostridium difficile infection. , 1998, The Journal of hospital infection.